| GCVTX | RMFEX | GCVTX / RMFEX | |
| Total Expense Ratio | 0.67 | 0.62 | 108% |
| Annual Report Gross Expense Ratio | 0.77 | 0.62 | 124% |
| Fund Existence | 18 years | 24 years | - |
| Gain YTD | 4.133 | 2.483 | 166% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 637M | 112B | 1% |
| Annual Yield % from dividends | 1.11 | 1.53 | 72% |
| Returns for 1 year | 10.73 | 10.91 | 98% |
| Returns for 3 years | 22.67 | 29.74 | 76% |
| Returns for 5 years | 21.47 | 47.00 | 46% |
| Returns for 10 years | 94.56 | 119.31 | 79% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| KDEC | 26.49 | 0.08 | +0.31% |
| Innovator U.S. Small Cp Pwr Buf ETF -Dec | |||
| IWLG | 53.50 | 0.04 | +0.08% |
| NYLI Winslow Large Cap Growth ETF | |||
| EVIM | 53.48 | 0.02 | +0.04% |
| Eaton Vance Intermediate Muncpl Inc ETF | |||
| AMLP | 49.10 | -0.02 | -0.04% |
| Alerian MLP ETF | |||
| FTXH | 33.46 | -0.25 | -0.74% |
| First Trust Nasdaq Pharmaceuticals ETF | |||